Clinical Trial: NI-0801 in Allergic Contact Dermatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Proof-of-Principle Study Investigating the Effect of Single Doses of NI-0801 on Nickel Induced Contact Dermatitis

Brief Summary: The purpose of the study is to assess the effect of a single dose of NI-0801 on the severity of nickel-induced allergic contact dermatitis.

Detailed Summary:
Sponsor: NovImmune SA

Current Primary Outcome: Effect of NI-0801 administration on the severity of the cutaneous response to Nickel challenge as measured using the score system of the DKG (Deutsche Kontakt-Allergie Gruppe).

Original Primary Outcome: Same as current

Current Secondary Outcome: Safety and tolerability of NI-0801 as measured by the incidence and severity of treatment emergent adverse events.

Original Secondary Outcome: Same as current

Information By: NovImmune SA

Dates:
Date Received: November 16, 2010
Date Started:
Date Completion:
Last Updated: November 18, 2010
Last Verified: November 2010